Infectious Disease · Public Health · 4 h ago
Klebsiella pneumoniae ST6668 detected across six EU countries
A preliminary analysis of genomic surveillance data detected carbapenemase-producing Klebsiella pneumoniae sequence type ST6668 across 19 regions in six EU countries. The findings cover April 2022 to August 2026 and highlight cross-border spread of this high-risk lineage.
- ST6668 detected in 19 regions across six EU countries
- Eight affected regions were in Italy
- Analysis used genomic surveillance data
- Authors cite patient mobility as a route of spread
Researchers analysed genomic surveillance data from the European Antimicrobial Resistance Gene Surveillance Network to assess the spread of carbapenemase-producing Klebsiella pneumoniae ST6668 between April 2022 and August 2026.
The preliminary analysis detected the sequence type in 19 NUTS-2 regions: eight in Italy and 11 across five other EU countries. The authors say the findings show how local outbreaks may spread between healthcare facilities through national and cross-border patient mobility. The source provides no patient-level counts or clinical outcomes, and describes the analysis as preliminary.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Eurosurveillance: Rapid inter-regional and cross-border dissemination of carbapenemase-producing Klebsiella pneumoniae ST6668, European Union, April 2022 to August 2026 ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.